Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells
Open Access
- 7 March 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 12 (1), 82
- https://doi.org/10.1186/1471-2407-12-82
Abstract
Background: The membrane cytoskeletal crosslinker, ezrin, a member of the ERM family of proteins, is frequently over-expressed in human breast cancers, and is required for motility and invasion of epithelial cells. Our group previously showed that ezrin acts co-operatively with the non-receptor tyrosine kinase, Src, in deregulation of cell-cell contacts and scattering of epithelial cells. In particular, ezrin phosphorylation on Y477 by Src is specific to ezrin within the ERM family, and is required for HGF-induced scattering of epithelial cells. We therefore sought to examine the role of Y477 phosphorylation in ezrin on tumor progression. Methods: Using a highly metastatic mouse mammary carcinoma cell line (AC2M2), we tested the effect of over-expressing a non-phosphorylatable form of ezrin (Y477F) on invasive colony growth in 3-dimensional Matrigel cultures, and on local invasion and metastasis in an orthotopic engraftment model. Results: AC2M2 cells over-expressing Y477F ezrin exhibited delayed migration in vitro, and cohesive round colonies in 3-dimensional Matrigel cultures, compared to control cells that formed invasive colonies with branching chains of cells and numerous actin-rich protrusions. Moreover, over-expression of Y477F ezrin inhibits local tumor invasion in vivo. Whereas orthotopically injected wild type AC2M2 tumor cells were found to infiltrate into the abdominal wall and visceral organs within three weeks, tumors expressing Y477F ezrin remained circumscribed, with little invasion into the surrounding stroma and abdominal wall. Additionally, Y477F ezrin reduces the number of lung metastatic lesions. Conclusions: Our study implicates a role of Y477 ezrin, which is phosphorylated by Src, in regulating local invasion and metastasis of breast carcinoma cells, and provides a clinically relevant model for assessing the Src/ezrin pathway as a potential prognostic/predictive marker or treatment target for invasive human breast cancer.Keywords
This publication has 50 references indexed in Scilit:
- Organizing the cell cortex: the role of ERM proteinsNature Reviews Molecular Cell Biology, 2010
- Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D CulturePLoS Computational Biology, 2010
- Is Expression or Activation of Src Kinase Associated with Cancer-Specific Survival in ER-, PR- and HER2-Negative Breast Cancer Patients?The American Journal of Pathology, 2009
- The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cellsNeuro-Oncology, 2009
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival SignalsCancer Cell, 2009
- Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent DatasetsPLOS ONE, 2008
- Spatial recruitment and activation of the Fes kinase by ezrin promotes HGF-induced cell scatteringThe EMBO Journal, 2007
- ERM proteins in epithelial cell organization and functionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Three-dimensional culture models of normal and malignant breast epithelial cellsNature Methods, 2007
- Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transitionCurrent Opinion in Cell Biology, 2005